# Sacubitril/valsartan and quality of life assessed using the EuroQol Five-dimension Three-level questionnaire level sum score (EQ-5D-3L-LSS) in patients with HFrEF and HFmrEF/HFpEF

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/sacubitril-valsartan-and-quality-of-life-assessed-using-the-euroqol-five/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Mingming Yang,Alasdair D Henderson,Inder S. Anand,Akshay S. Desai,Carolyn S.P. Lam,Aldo P. Maggioni,Felipe A. Martínez,Jean L. Rouleau,Karl Swedberg,Muthiah Vaduganathan,Dirk J van Veldhuisen,Faı̈ez Zannad,Michael R. Zile,Milton Packer,Adel R. Rizkala,Eldrin F. Lewis,Pardeep S. Jhund,Scott D. Solomon,John J.V. McMurray |
| Citations | 1 |
| DOI | 10.1093/ehjcvp/pvaf064 |
| Fields | Economics, Econometrics and Finance,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://academic.oup.com/ehjcvp/advance-article-pdf/doi/10.1093/ehjcvp/pvaf064/64104448/pvaf064.pdf |
| OpenAlex ID | https://openalex.org/W4413394227 |
| PMID | 40839760 |
| Type | article |
| Year | 2025 |

## Paper authors

- [Scott D. Solomon](https://scholariq.org/researchers/scott-d-solomon/)
- [Faı̈ez Zannad](https://scholariq.org/researchers/fa-ez-zannad/)
- [Milton Packer](https://scholariq.org/researchers/milton-packer/)
- [Aldo P. Maggioni](https://scholariq.org/researchers/aldo-p-maggioni/)
- [John J.V. McMurray](https://scholariq.org/researchers/john-j-v-mcmurray/)

## Paper funders

Showing 8 of 16.

- [American Heart Association](https://scholariq.org/funders/american-heart-association/)
- [Amgen](https://scholariq.org/funders/amgen/)
- [Eli Lilly and Company](https://scholariq.org/funders/eli-lilly-and-company/)
- [AstraZeneca](https://scholariq.org/funders/astrazeneca/)
- [Bayer](https://scholariq.org/funders/bayer/)
- [Brigham and Women's Hospital](https://scholariq.org/funders/brigham-and-women-s-hospital/)
- [Alexion Pharmaceuticals](https://scholariq.org/funders/alexion-pharmaceuticals/)
- [Alnylam Pharmaceuticals](https://scholariq.org/funders/alnylam-pharmaceuticals/)

## Paper journal

- [European Heart Journal - Cardiovascular Pharmacotherapy](https://scholariq.org/journals/european-heart-journal-cardiovascular-pharmacotherapy/)

## Paper primary topic

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)

## Paper topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.